Biogen Gets FDA, EMA Approval to Study Higher Dose Regimen of Spinal Muscular Atrophy Treatment

MT NewswiresJan 23 07:55 ET

Express News | FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in Sma

ReutersJan 23 07:30 ET

S&P 500 Futures Climb In Premarket Trading; Tempus AI, IDACORP Lead

Dow JonesJan 21 07:30 ET

Ionis Pharmaceuticals Insider Sold Shares Worth $1,091,444, According to a Recent SEC Filing

MT NewswiresJan 21 03:08 ET

Insider Sale: EVP Research of $IONS (IONS) Sells 7,154 Shares

Quiver QuantitativeJan 17 19:45 ET

Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock With Biggest Upside Potential

Yahoo FinanceJan 17 11:22 ET